Retroperitoneal hematoma in patients with COVID-19 infection during anticoagulant therapy: A case series and literature review

Due to the hypercoagulable status of patients with severe COVID-19 infection, anticoagulants are often used to prevent thrombosis. However, these agents may cause bleeding events such as retroperitoneal hematoma (RPH). We report here on six patients with COVID-19 who developed RPH during treatment....

Descripción completa

Detalles Bibliográficos
Autores principales: Hashemi, Huriyeh, Moradi, Hazhir, Hashemi, Marzieh, Naderi, Zohre, Jafarpisheh, Saleh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465591/
https://www.ncbi.nlm.nih.gov/pubmed/36076361
http://dx.doi.org/10.1177/03000605221119662

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465591/
https://www.ncbi.nlm.nih.gov/pubmed/36076361
http://dx.doi.org/10.1177/03000605221119662

Ejemplares similares